These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
326 related items for PubMed ID: 19240253
1. Breakdown of endocytosis in the oncogenic activation of receptor tyrosine kinases. Abella JV, Park M. Am J Physiol Endocrinol Metab; 2009 May; 296(5):E973-84. PubMed ID: 19240253 [Abstract] [Full Text] [Related]
3. Tyrosine kinase receptors as attractive targets of cancer therapy. Bennasroune A, Gardin A, Aunis D, Crémel G, Hubert P. Crit Rev Oncol Hematol; 2004 Apr; 50(1):23-38. PubMed ID: 15094157 [Abstract] [Full Text] [Related]
4. In control at the ER: PTP1B and the down-regulation of RTKs by dephosphorylation and endocytosis. Stuible M, Tremblay ML. Trends Cell Biol; 2010 Nov; 20(11):672-9. PubMed ID: 20864346 [Abstract] [Full Text] [Related]
5. Ubiquitin in trafficking: the network at work. Acconcia F, Sigismund S, Polo S. Exp Cell Res; 2009 May 15; 315(9):1610-8. PubMed ID: 19007773 [Abstract] [Full Text] [Related]
6. Defective downregulation of receptor tyrosine kinases in cancer. Bache KG, Slagsvold T, Stenmark H. EMBO J; 2004 Jul 21; 23(14):2707-12. PubMed ID: 15229652 [Abstract] [Full Text] [Related]
10. Monitoring interactions between receptor tyrosine kinases and their downstream effector proteins in living cells using bioluminescence resonance energy transfer. Tan PK, Wang J, Littler PL, Wong KK, Sweetnam TA, Keefe W, Nash NR, Reding EC, Piu F, Brann MR, Schiffer HH. Mol Pharmacol; 2007 Dec 21; 72(6):1440-6. PubMed ID: 17715395 [Abstract] [Full Text] [Related]
11. Quantitative mass spectrometry to investigate epidermal growth factor receptor phosphorylation dynamics. Schuchardt S, Borlak J. Mass Spectrom Rev; 2008 Dec 21; 27(1):51-65. PubMed ID: 18023079 [Abstract] [Full Text] [Related]
12. Small tyrosine kinase inhibitors as key molecules in the expression of metalloproteinases by solid tumors. Stahtea XN, Kousidou OCh, Roussidis AE, Tzanakakis GN, Karamanos NK. Connect Tissue Res; 2008 Dec 21; 49(3):211-4. PubMed ID: 18661345 [Abstract] [Full Text] [Related]
14. Oncogenic activation of the Met receptor tyrosine kinase fusion protein, Tpr-Met, involves exclusion from the endocytic degradative pathway. Mak HH, Peschard P, Lin T, Naujokas MA, Zuo D, Park M. Oncogene; 2007 Nov 08; 26(51):7213-21. PubMed ID: 17533376 [Abstract] [Full Text] [Related]
15. Western blotting analysis as a tool to study receptor tyrosine kinases. Germano S, O'Driscoll L. Methods Mol Biol; 2011 Nov 08; 784():109-21. PubMed ID: 21898216 [Abstract] [Full Text] [Related]
16. Receptor tyrosine kinases and their activation in melanoma. Easty DJ, Gray SG, O'Byrne KJ, O'Donnell D, Bennett DC. Pigment Cell Melanoma Res; 2011 Jun 08; 24(3):446-61. PubMed ID: 21320293 [Abstract] [Full Text] [Related]
17. Get off my back! Rapid receptor internalization through circular dorsal ruffles. Orth JD, McNiven MA. Cancer Res; 2006 Dec 01; 66(23):11094-6. PubMed ID: 17145849 [Abstract] [Full Text] [Related]
18. Signaling and endocytosis: a team effort for cell migration. Le Roy C, Wrana JL. Dev Cell; 2005 Aug 01; 9(2):167-8. PubMed ID: 16054022 [Abstract] [Full Text] [Related]